Mark Lappe

Insider Reports History

Location
San Diego, CA
Signature
/s/ Kelly D. Deck, as attorney-in-fact for Mark P. Lappe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Lappe:

Company Role Class Num Shares Value Price $ Report Date Ownership
Inhibrx Biosciences, Inc. Chief Executive Officer, Director Common Stock 705,548 $12,086,037 $17.13 16 Sep 2024 By the Lappe Family Trust
Inhibrx Biosciences, Inc. Chief Executive Officer, Director Common Stock 165,000 $2,826,450 $17.13 12 Sep 2024 By Lappe Descendants' Trust
Inhibrx Biosciences, Inc. Chief Executive Officer, Director Common Stock 54,865 $939,837 $17.13 12 Sep 2024 The Mark Paul Lappe Roth IRA
Inhibrx, Inc. Chief Executive Officer, Director Common Stock 0 $0 $30.00 30 May 2024 By the Lappe Family Trust
Inhibrx, Inc. Chief Executive Officer, Director Common Stock 0 $0 $30.00 30 May 2024 By trust
Inhibrx, Inc. Chief Executive Officer, Director Common Stock 0 $0 $30.00 30 May 2024 The Mark Paul Lappe Roth IRA
Inhibrx, Inc. Chief Executive Officer, Director Stock Option (right to buy) 0 $0 $34.12 30 May 2024 Direct
Inhibrx Biosciences, Inc. Chief Executive Officer, Director Stock Option (right to buy) 300,000 30 May 2024 Direct

Insider Reports Filed by Mark Lappe

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INBX Inhibrx Biosciences, Inc. 12 Sep 2024 2 +$629,117 4 Chief Executive Officer, Director 16 Sep 2024, 17:12
INBX Inhibrx Biosciences, Inc. 06 Sep 2024 3 +$671,150 4 Chief Executive Officer, Director 10 Sep 2024, 17:00
INBX Inhibrx Biosciences, Inc. 29 Aug 2024 4 +$596,763 4 Chief Executive Officer, Director 03 Sep 2024, 17:31
INBX Inhibrx Biosciences, Inc. 20 Aug 2024 2 +$518,282 4 Chief Executive Officer, Director 22 Aug 2024, 16:29
/report/000095014224001500-lappe-mark-2024-05-30 Inhibrx, Inc. 30 May 2024 5 -$91,369,620 4 Chief Executive Officer, Director 30 May 2024, 18:22
INBX Inhibrx Biosciences, Inc. 29 May 2024 4 $0 4 Chief Executive Officer, Director 30 May 2024, 18:10
INBX Inhibrx Biosciences, Inc. 24 May 2024 0 $0 3 Chief Executive Officer, Director 24 May 2024, 16:47
/report/000173961423000014-lappe-mark-2023-02-28 Inhibrx, Inc. 28 Feb 2023 1 -$1,501 4 Chief Executive Officer, Director 01 Mar 2023, 15:41
/report/000173961423000010-lappe-mark-2023-01-23 Inhibrx, Inc. 23 Jan 2023 3 -$660,842 4 Chief Executive Officer, Director 24 Jan 2023, 17:46
/report/000173961423000004-lappe-mark-2023-01-03 Inhibrx, Inc. 03 Jan 2023 1 $0 4 Chief Executive Officer, Director 03 Jan 2023, 17:11
/report/000173961422000130-lappe-mark-2022-12-19 Inhibrx, Inc. 19 Dec 2022 2 -$664,443 4 Chief Executive Officer, Director 20 Dec 2022, 15:59
/report/000173961422000124-lappe-mark-2022-11-17 Inhibrx, Inc. 17 Nov 2022 7 -$724,910 4 Chief Executive Officer, Director 18 Nov 2022, 16:06
/report/000173961422000107-lappe-mark-2022-10-17 Inhibrx, Inc. 17 Oct 2022 4 -$769,443 4 Chief Executive Officer, Director 18 Oct 2022, 16:37